Eve Bender June 20, 2024 A position statement released by the American Headache Society (AHS) earlier this year recommended adding calcitonin gene-related peptide (CGRP)–targeting medications to the list of first-line therapies for migraine prevention. The guidance replaces recommendations published in 2021 that advised clinicians consider CGRP therapy only after patients fail at least two classes...
Tag: <span>Migraine</span>
Post
No Link Between Habitual Caffeine Use and Migraine
Batya Swift Yasgur TOPLINE:Habitual consumption of caffeine is not associated with frequency, duration, or intensity of episodic migraines, a new study showed. Investigators said the findings suggest caffeine restrictions in migraineurs may not be necessary. METHODOLOGY:The secondary analysis of a prospective cohort study on sleep in adults with episodic migraine (with or without aura) included...
Post
CGRP in Migraine Prodrome Can Stop Headache, Reduce Severity
Sue Hughes BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In the randomized, placebo-controlled crossover PRODROME trial, treatment with ubrogepant (Ubrelvy) 100 mg, one of the new CGRP receptor antagonists, during the prodrome...
Post
The combination of migraine and persistent hot flashes could prove deadly
New study suggests that women with both migraine and persistent hot flashes face double the risk of heart disease and triple the risk of strokePeer-Reviewed Publication THE MENOPAUSE SOCIETY CLEVELAND, Ohio (Feb 14, 2024)—Hot flashes and migraine (particularly with aura) have been shown to be individual risk factors for cardiovascular disease because of associated poorer...
Post
Secondhand Smoke Exposure Linked to Migraine, Severe Headache
TOPLINE:Heavy secondhand smoke (SHS) exposure is associated with severe headache or migraine in adults who have never smoked, with effects of exposure varying depending on body mass index (BMI) and level of physical activity, new research shows. METHODOLOGY:Investigators analyzed data on 4560 participants (median age, 43 years; 60% female; 71.5% White) from the 1999-2004 National...
Post
CGRP in Migraine Prodrome Can Stop Headache, Reduce Severity
BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In the randomized, placebo-controlled crossover PRODROME trial, treatment with ubrogepant (Ubrelvy) 100 mg, one of the new CGRP receptor antagonists, during the prodrome prevented the...
Post
A large international study of migraine reveals new biological pathways for treatment
by deCODE genetics Credit: Pixabay/CC0 Public DomainA large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of novel drug targets. In a study published in Nature Genetics a group of...
Post
New study shows common blood pressure meds underused for migraine
by George Institute for Global Health Credit: Pixabay/CC0 Public Domain The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these common drugs could be used much more widely, at low cost, than is the case with current practice, according to a new...
Post
Head-to-Head Comparison of 25 Migraine Meds Reveals Top Options
Megan Brooks May 02, 2023 When it comes to relieving migraine headache, triptans, ergots, and antiemetics are the most effective classes of medications, a new real-world analysis of data on more than 3 million migraine attacks shows. Dr Chia-Chun Chiang The findings “align with results of clinical trials and recommendations from clinical treatment guidelines” and provide insights to complement clinical practice, study investigator Chia-Chun...
Post
Migraine as a neurological condition
By Yale University Anyone who thinks of a migraine as “just a headache” has likely never had one, as the condition can be debilitating and painful. Migraine is a neurologic disorder that not only causes headaches, but often also a constellation of symptoms that can impact daily living, explains Jason Sico, MD, MHS, a Yale...